Drawing for CETYA THERAPEUTICS

USPTO serial 86504253

CETYA THERAPEUTICS

Reviewed by CopyMark Law Group

Reg. 5105623Status 710
Filing date
Status date
Registration date
Dec 20, 2016
Examiner
CUCCIAS, MATTHEW JAMES
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with CETYA THERAPEUTICS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Stephanie S. Brannen

STEPHANIE S. BRANNEN WILSON SONSINI GOODRICH & ROSATI650 PAGE MILL RDPALO ALTO, CA 94304-1050UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceuticals and pharmaceutical products in the nature of histone deacetylase (HDAC) inhibitors for the treatment of cancer, autoimmune disorders and conditions, hemoglobinopathy disorders and conditions, metabolic diseases, acute and chronic inflammatory diseases, cardiac diseases, and genetic diseases; pharmaceuticals and pharmaceutical products for treating cancer, autoimmune disorders and conditions, hemoglobinopathy disorders and conditions, metabolic diseases, acute and chronic inflammatory diseases, cardiac diseases, and genetic diseasesSECTION 8 - CANCELLEDSep 29, 2016
042Medical research; medical and scientific research services all in the fields of oncology, autoimmune disorders and conditions, hemoglobinopathies, metabolic diseases, acute and chronic inflammatory diseases, cardiac diseases, and genetic diseasesSECTION 8 - CANCELLEDMar 31, 2016

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 30, 2023C8..CANCELLED SEC. 8 (6-YR)—
Dec 20, 2021REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Dec 20, 2016R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 15, 2016SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Nov 12, 2016CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Nov 4, 2016SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Oct 29, 2016AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Oct 14, 2016IUAFUSE AMENDMENT FILED—
Oct 14, 2016EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
May 3, 2016NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 8, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 8, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 17, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 29, 2016PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jan 22, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 20, 2016XAECEXAMINER'S AMENDMENT ENTERED—
Jan 20, 2016GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jan 20, 2016GNEAEXAMINERS AMENDMENT E-MAILED—
Jan 20, 2016CNEAEXAMINERS AMENDMENT -WRITTEN—
Jan 14, 2016ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Dec 8, 2015PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Nov 23, 2015PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Nov 18, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 16, 2015TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 16, 2015CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 9, 2015ALIEASSIGNED TO LIE—
Oct 20, 2015TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 21, 2015GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 21, 2015GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 21, 2015CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 21, 2015DOCKASSIGNED TO EXAMINER—
Jan 29, 2015MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Jan 28, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 19, 2015NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance